"The new GLP-1 pills are underwhelming compared to injections, with oral Wegovy needing to be taken on an empty stomach and with limited water intake."
"Even though many GLP-1 users hit a weight-loss plateau after several months, they have to continue injecting themselves to avoid gaining the weight back."
"The psychological burden of ongoing injections can become more apparent, particularly as patients transition from the active-weight-loss phase to long-term maintenance."
The new GLP-1 weight-loss pills are less effective than their injectable counterparts, with oral Wegovy requiring specific conditions for use. Despite the convenience of pills, users still face side effects like nausea and diarrhea. The injections, while effective, pose challenges such as scheduling and refrigeration. Many users experience a weight-loss plateau and must continue injections to maintain weight loss. The psychological burden of ongoing injections can become significant over time, highlighting the potential value of weight-loss pills for long-term management.
Read at The Atlantic
Unable to calculate read time
Collection
[
|
...
]